Hardy J, Selkoe DJ. Medication– The amyloid hypothesis of Alzheimer’s illness: Development and issues on the roadway to rehabs. Science. 2002; 297:353– 6.
Google Scholar.
Ismail R, Parbo P, Madsen LS, Hansen AK, Hansen KV, Schaldemose JL, et al. The relationships in between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s illness: a longitudinal family pet research study. J Neuroinflammation. 2020; 17:151.
Google Scholar.
Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, et al. Hereditary proof links the body immune system and cholesterol metabolic process in the aetiology of Alzheimer’s illness. PLoS ONE. 2010; 5: e13950.
Google Scholar.
Calsolaro V, Edison P. Neuroinflammation in Alzheimer’s illness: Existing proof and future instructions. Alzheimers Dement. 2016; 12:719– 32.
Google Scholar.
Delbeuck X, Van der Linden M, Collette F. Alzheimer’s illness as a disconnection syndrome? Neuropsychol Rev. 2003; 13:79– 92.
Google Scholar.
Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, et al. Loss of connection in Alzheimer’s illness: an assessment of white matter system stability with colour coded MR diffusion tensor imaging. J Neurol Neurosur Psychiatry. 2000; 69:528– 30.
Google Scholar.
Brier MR, Thomas JB, Ances BM. Network dysfunction in Alzheimer’s illness: fine-tuning the disconnection hypothesis. Brain Link. 2014; 4:299– 311.
Google Scholar.
Hahn K, Myers N, Prigarin S, Rodenacker K, Kurz A, Forstl H, et al. Selectively and gradually interrupted structural connection of practical brain networks in Alzheimer’s illness– exposed by an unique structure to examine edge circulations of networks discovering interruptions with strong analytical proof. Neuroimage. 2013; 81:96– 109.
Google Scholar.
Bosch B, Arenaza-Urquijo EM, Rami L, Sala-Llonch R, Junque C, Sole-Padulles C, et al. Numerous DTI index analysis in typical aging, amnestic MCI and advertisement. Relationship with neuropsychological efficiency. Neurobiol Aging. 2012; 33:61– 74.
Google Scholar.
Stress JF, Smith RX, Beaumont H, Roe CM, Gordon Bachelor’s Degree, Mishra S, et al. Loss of white matter stability shows tau build-up in Alzheimer illness specified areas. Neurology. 2018; 91: e313– 8.
Google Scholar.
Kantarci K, Murray ME, Schwarz CG, Reid RI, Przybelski SA, Lesnick T, et al. White-matter stability on DTI and the pathologic staging of Alzheimer’s illness. Neurobiol Aging. 2017; 56:172– 9.
Google Scholar.
Melah KE, Lu SY, Hoscheidt SM, Alexander AL, Adluru N, Destiche DJ, et al. Cerebrospinal Fluid Markers of Alzheimer’s Illness Pathology and Microglial Activation are Connected With Transformed White Matter Microstructure in Asymptomatic Grownups at Danger for Alzheimer’s Illness. J Alzheimers Dis. 2016; 50:873– 86.
Google Scholar.
Gold BT, Zhu Z, Brown CA, Andersen AH, Ladu MJ, Tai L, et al. White matter stability is related to cerebrospinal fluid markers of Alzheimer’s illness in typical grownups. Neurobiol Aging. 2014; 35:2263– 71.
Google Scholar.
Nave KA, Trapp BD. Axon-glial signaling and the glial assistance of axon function. Annu Rev Neurosci. 2008; 31:535– 61.
Google Scholar.
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The medical diagnosis of dementia due to Alzheimer’s illness: suggestions from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic standards for Alzheimer’s illness. Alzheimers Dement. 2011; 7:263– 9.
Google Scholar.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The medical diagnosis of moderate cognitive disability due to Alzheimer’s illness: suggestions from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic standards for Alzheimer’s illness. Alzheimers Dement. 2011; 7:270– 9.
Google Scholar.
Thurfjell L, Lilja J, Lundqvist R, Buckley C, Smith A, Vandenberghe R, et al. Automated metrology of 18F-flutemetamol family pet activity for classifying scans as unfavorable or favorable for brain amyloid: concurrence with visual image checks out. J Nucl Medication. 2014; 55:1623– 8.
Google Scholar.
Lyoo CH, Ikawa M, Liow JS, Zoghbi SS, Morse CL, Pike VW, et al. Cerebellum Can Work As a Pseudo-Reference Area in Alzheimer Illness to Find Neuroinflammation Determined with Animal Radioligand Binding to Translocator Protein. J Nucl Medication. 2015; 56:701– 6.
Google Scholar.
Fischl B, Dale AM. Determining the density of the human cortex from magnetic resonance images. Proc Natl Acad Sci U.S.A.. 2000; 97:11050– 5.
Google Scholar.
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, et al. Advances in practical and structural MR image analysis and application as FSL. Neuroimage. 2004; 23: S208– 19.
Google Scholar.
Wang J, Wang X, Xia M, Liao X, Evans A, He Y. GRETNA: a chart theoretical network analysis tool kit for imaging connectomics. Front Hum Neurosci. 2015; 9:386.
Smith SM, Nichols TE. Threshold-free cluster improvement: dealing with issues of smoothing, limit reliance and localisation in cluster reasoning. Neuroimage. 2009; 44:83– 98.
Google Scholar.
Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Study Structure: Towards a biological meaning of Alzheimer’s illness. Alzheimers Dement. 2018; 14:535– 62.
Google Scholar.
Witten DM, Tibshirani R, Hastie T. A punished matrix decay, with applications to sporadic primary elements and canonical connection analysis. Biostatistics. 2009; 10:515– 34.
Google Scholar.
Tingley D, Yamamoto T, Hirose K, Keele L, Imai K. mediation: R Bundle for Causal Mediation Analysis. J Stat Softw. 2014; 59:1– 38.
Google Scholar.
Webers A, Heneka MT, Gleeson PA. The function of inherent immune reactions and neuroinflammation in amyloid build-up and development of Alzheimer’s illness. Immunol Cell Biol. 2020; 98:28– 41.
Google Scholar.
Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, et al. Microglia, amyloid, and cognition in Alzheimer’s illness: An [11C]( R) PK11195-PET and [11C] PIB-PET research study. Neurobiol Dis. 2008; 32:412– 9.
Google Scholar.
Malpetti M, Kievit RA, Passamonti L, Jones PS, Tsvetanov KA, Rittman T, et al. Microglial activation and tau problem forecast cognitive decrease in Alzheimer’s illness. Brain. 2020; 143:1588– 602.
Google Scholar.
Zou J, Tao S, Johnson A, Tomljanovic Z, Polly K, Klein J, et al. Microglial activation, however not tau pathology, is individually related to amyloid positivity and memory disability. Neurobiol Aging. 2020; 85:11– 21.
Google Scholar.
Dani M, Wood M, Mizoguchi R, Fan Z, Walker Z, Morgan R, et al. Microglial activation associates in vivo with both tau and amyloid in Alzheimer’s illness. Brain. 2018; 141:2740– 54.
Felsky D, Roostaei T, Nho K, Risacher SL, Bradshaw EM, Petyuk V, et al. Neuropathological correlates and hereditary architecture of microglial activation in senior human brain. Nat Commun. 2019; 10:409.
Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity differentiates Alzheimer’s illness from healthy aging: Proof from practical MRI. Proc Natl Acad Sci U.S.A.. 2004; 101:4637– 42.
Google Scholar.
Brier MR, Thomas JB, Snyder AZ, Benzinger TL, Zhang D, Raichle ME, et al. Loss of intranetwork and internetwork resting state practical connections with Alzheimer’s illness development. J Neurosci. 2012; 32:8890– 9.
Google Scholar.
Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative illness target massive human brain networks. Nerve cell. 2009; 62:42– 52.
Google Scholar.
Supekar K, Menon V, Rubin D, Musen M, Greicius MD. Network analysis of intrinsic practical brain connection in Alzheimer’s illness. PLoS Comput Biol. 2008; 4: e1000100.
Google Scholar.
Tait L, Stothart G, Coulthard E, Brown JT, Kazanina N, Goodfellow M. Network substrates of cognitive disability in Alzheimer’s Illness. Clin Neurophysiol. 2019; 130:1581– 95.
Google Scholar.
Honey CJ, Sporns O, Cammoun L, Gigandet X, Thiran JP, Meuli R, et al. Forecasting human resting-state practical connection from structural connection. Proc Natl Acad Sci U.S.A.. 2009; 106:2035– 40.
Google Scholar.
Gold BT, Johnson NF, Powell DK, Smith CD. White matter stability and vulnerability to Alzheimer’s illness: initial findings and future instructions. Biochim Biophys Acta. 2012; 1822:416– 22.
Google Scholar.
Frost B, Diamond MI. Prion-like systems in neurodegenerative illness. Nat Rev Neurosci. 2010; 11:155– 9.
Google Scholar.
Jacobs HIL, Hedden T, Schultz AP, Sepulcre J, Perea RD, Amariglio RE, et al. Structural system modifications forecast downstream tau build-up in amyloid-positive older people. Nat Neurosci. 2018; 21:424– 31.
Google Scholar.
Passamonti L, Tsvetanov KA, Jones PS, Bevan-Jones WR, Arnold R, Borchert RJ, et al. Neuroinflammation and Practical Connection in Alzheimer’s Illness: Interactive Impacts on Cognitive Efficiency. J Neurosci. 2019; 39:7218– 26.
Wolf D, Fischer FU, Scheurich A, Fellgiebel A, Alzheimer’s Illness Neuroimaging I. Non-Linear Association in between Cerebral Amyloid Deposition and White Matter Microstructure in Cognitively Healthy Older Grownups. J Alzheimers Dis. 2015; 47:117– 27.
Google Scholar.
Herrup K. The case for declining the amyloid waterfall hypothesis. Nat Neurosci. 2015; 18:794– 9.
Google Scholar.
Michell-Robinson MA, Touil H, Healy LM, Owen DR, Durafourt Bachelor’s Degree, Bar-Or A, et al. Functions of microglia in brain advancement, tissue repair and maintenance. Brain. 2015; 138:1138– 59.
Google Scholar.
Baalman K, Marin MA, Ho TS, Godoy M, Cherian L, Robertson C, et al. Axon preliminary segment-associated microglia. J Neurosci. 2015; 35:2283– 92.
Google Scholar.
Davies DS, Ma J, Jegathees T, Goldsbury C. Microglia reveal modified morphology and minimized arborization in human brain throughout aging and Alzheimer’s illness. Brain Pathol. 2017; 27:795– 808.
Google Scholar.
Peferoen L, Kipp M, van der Valk P, van Noort JM, Amor S. Oligodendrocyte-microglia cross-talk in the main nerve system. Immunology. 2014; 141:302– 13.
Google Scholar.
Marin MA, Ziburkus J, Jankowsky J, Rasband MN. Amyloid-beta plaques interrupt axon preliminary sections. Exp Neurol. 2016; 281:93– 8.
Google Scholar.
Takeuchi H, Mizuno T, Zhang G, Wang J, Kawanokuchi J, Kuno R, et al. Neuritic beading caused by triggered microglia is an early function of neuronal dysfunction towards neuronal death by inhibition of mitochondrial respiration and axonal transportation. J Biol Chem. 2005; 280:10444– 54.
Google Scholar.
La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, et al. Potential longitudinal atrophy in Alzheimer’s illness associates with the strength and topography of standard tau-PET. Sci Transl Medication. 2020; 12: eaau5732.
Google Scholar.
Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, et al. Microglial activation and tau propagate collectively throughout Braak phases. Nat Medication. 2021; 27:1592– 9.
Google Scholar.
Femminella GD, Dani M, Wood M, Fan Z, Calsolaro V, Atkinson R, et al. Microglial activation in early Alzheimer trajectory is related to greater noodle volume. Neurology. 2019; 92: e1331– 43.
Google Scholar.
Fan Z, Brooks DJ, Okello A, Edison P. An early and late peak in microglial activation in Alzheimer’s illness trajectory. Brain. 2017; 140:792– 803.
